+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

Overweight and Obesity Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Overweight and Obesity Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • January 2023
  • 52 Pages
  • Global
From
Obesity: Competitive Landscape to 2026 - Product Thumbnail Image

Obesity: Competitive Landscape to 2026

  • Report
  • October 2018
  • 50 Pages
  • Global
From
Anti-Obesity Drugs Companies in China - Product Thumbnail Image

Anti-Obesity Drugs Companies in China

  • Report
  • November 2023
  • 73 Pages
  • China
From
Anti-Obesity Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Anti-Obesity Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 87 Pages
  • China
From
Weight Loss/Weight Management (Obesity) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Weight Loss/Weight Management (Obesity) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 342 Pages
  • Global
From
Weight Loss/Weight Management (Obesity) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Weight Loss/Weight Management (Obesity) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 160 Pages
  • Global
From
Methylphenidate Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Methylphenidate Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • February 2024
  • 86 Pages
  • Global
From
Anti-obesity Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Anti-obesity Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • January 2024
  • 89 Pages
  • Global
From
Liraglutide Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Liraglutide Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 94 Pages
  • Global
From
Leptin Receptor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Leptin Receptor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • September 2023
  • 79 Pages
  • Global
From
Lifestyle Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Lifestyle Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 113 Pages
  • Global
From
Anti-Obesity Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Anti-Obesity Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • March 2022
  • 98 Pages
  • Global
From
Obesity Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Obesity Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 87 Pages
  • Global
From
Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 52 Pages
  • Global
From
Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 643 Pages
  • Global
From
Vietnam Non-invasive Fat Reduction Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Vietnam Non-invasive Fat Reduction Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • January 2024
  • 80 Pages
  • Vietnam
From
Russia Non-invasive Fat Reduction Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Russia Non-invasive Fat Reduction Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • January 2024
  • 80 Pages
  • Russia
From
Poland Non-invasive Fat Reduction Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Poland Non-invasive Fat Reduction Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • January 2024
  • 80 Pages
  • Poland
From
Japan Non-invasive Fat Reduction Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Japan Non-invasive Fat Reduction Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • January 2024
  • 80 Pages
  • Japan
From
Ireland Non-invasive Fat Reduction Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Ireland Non-invasive Fat Reduction Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • January 2024
  • 80 Pages
  • Ireland
From
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more